Growth Metrics

Standard Biotools (LAB) Other Non-Current Assets (2016 - 2025)

Standard Biotools (LAB) has disclosed Other Non-Current Assets for 16 consecutive years, with $230.7 million as the latest value for Q3 2025.

  • Quarterly Other Non-Current Assets rose 4871.47% to $230.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $230.7 million through Sep 2025, up 4871.47% year-over-year, with the annual reading at $43.0 million for FY2024, 1780.22% up from the prior year.
  • Other Non-Current Assets for Q3 2025 was $230.7 million at Standard Biotools, up from $6.5 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $230.7 million in Q3 2025, with the low at $1.0 million in Q2 2021.
  • Average Other Non-Current Assets over 5 years is $18.3 million, with a median of $3.6 million recorded in 2022.
  • The sharpest move saw Other Non-Current Assets plummeted 79.82% in 2021, then skyrocketed 4871.47% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $3.7 million in 2021, then dropped by 15.72% to $3.1 million in 2022, then fell by 26.5% to $2.3 million in 2023, then soared by 1780.22% to $43.0 million in 2024, then soared by 436.92% to $230.7 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $230.7 million, $6.5 million, and $43.0 million for Q3 2025, Q1 2025, and Q4 2024 respectively.